142 related articles for article (PubMed ID: 6211491)
21. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
Koistinen V
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
23. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
Pangburn MK
J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
[TBL] [Abstract][Full Text] [Related]
24. Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Baker PJ; Rosse WF
J Immunol; 1983 Nov; 131(5):2484-9. PubMed ID: 6226743
[TBL] [Abstract][Full Text] [Related]
25. Localization of the heparin-binding site on complement factor H.
Pangburn MK; Atkinson MA; Meri S
J Biol Chem; 1991 Sep; 266(25):16847-53. PubMed ID: 1832158
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
[TBL] [Abstract][Full Text] [Related]
27. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
28. Control of the immune complex-complement interaction by protein H of the alternative complement pathway and the natural inhibitor heparin.
Spycher MO; Nydegger UE
Eur J Immunol; 1984 Mar; 14(3):276-9. PubMed ID: 6231187
[TBL] [Abstract][Full Text] [Related]
29. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
30. Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies.
Isenman DE
J Biol Chem; 1983 Apr; 258(7):4238-44. PubMed ID: 6220003
[TBL] [Abstract][Full Text] [Related]
31. Use of monoclonal antibodies against factor H to investigate the role of a membrane-associated protein antigenically related to H in C3b-receptor function.
Schulz TF; Scheiner O; Alsenz J; Lambris JD; Dierich MP
J Immunol; 1984 Jan; 132(1):392-8. PubMed ID: 6197451
[TBL] [Abstract][Full Text] [Related]
32. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
Lambris JD; Dobson NJ; Ross GD
J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
[TBL] [Abstract][Full Text] [Related]
33. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Gigli I; Fujita T; Nussenzweig V
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
[TBL] [Abstract][Full Text] [Related]
35. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
36. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
Fries LF; Gaither TA; Hammer CH; Frank MM
J Exp Med; 1984 Dec; 160(6):1640-55. PubMed ID: 6239898
[TBL] [Abstract][Full Text] [Related]
37. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
38. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
Horstmann RD; Sievertsen HJ; Knobloch J; Fischetti VA
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1657-61. PubMed ID: 2964038
[TBL] [Abstract][Full Text] [Related]
39. Alternative pathway of complement.
Pangburn MK
Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
[No Abstract] [Full Text] [Related]
40. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.
Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
Clin Exp Immunol; 1985 Nov; 62(2):427-34. PubMed ID: 2935338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
